dccik bio-immunotherapy
A number of hospitals claimed to be used in the treatment of cancer DC-CIK bio-immunotherapy, recently triggered social concern. 5, the reporter learned from the second hospital of Shanxi Medical University, the hospital's biological oncology has been suspended in the clinical treatment of the application of DC-CIK technology.
The relevant person in charge of the hospital said, the hospital is in accordance with the requirements of the health department, for the efficacy of DC-CIK technology and other related situations for self-examination; in addition, the hospital and provide DC-CIK technology company's contract has expired. In view of the above, the hospital biological oncology suspended the application of this technology in clinical treatment.
The reporter noted that, since the 4th, the website of the Oncology Biotherapy Department of the Second Hospital of Shanxi Medical University has been unable to log in, and until now, it still shows "under maintenance". Previously, the website content said that the hospital is a "large public tertiary hospital ...... tumor biological section using biological cell immunotherapy, DC-CIK autologous cell immunotherapy and other latest cancer treatment technology ...... "
Nowadays, cellular immunotherapy is a treatment that is regarded as a lifesaver by many cancer patients, and the cellular immunotherapies that are widely used in China at present include DC, CIK, DC-CIK, and so on. Some media reports said that on May 4, the National Health and Family Planning Commission held a video conference to make it clear that cellular immunotherapy is still in the clinical research stage; participants revealed that the official request to stop its application in clinical treatment, but limited to clinical research.
dccik bio-immunotherapy is real
1. They say it is the technology introduced by the United States, but there is very little content from the google search of the DC-CIK English web page.
2. No papers on this technology can be found at home or abroad.
3. I've read the biography of Steve Jobs, which talks about his treatment method, saying that he started using a new treatment method in 11 years, which was implemented by a group of top scientists, and that he was either one of the first to go ashore or one of the last to drown. The description of this method is that it recognizes the cancer cell and destroys him. The description is similar to this DC-CIK therapy, but it was used in this country 3 years ago.
4. I found out that the company that operates this therapy in China is this company:/Shengwuzhiliao.php The description of this page shows that this technology is what he is doing, and it is not imported from the US at all, while his clients who are big hospitals, all claim that it is imported from the US. Last year, this website also has an English page, is introduced to foreign customers to see a doctor in the country, that foreign countries do not have this technology. This year this page can no longer be found.
5. Last year, I saw a news from the Internet, saying that scientists have newly discovered a kind of protective enzyme that can break through the surface of cancer cells, and this kind of enzyme is equivalent to the camouflage of the cancer cells, which can make him avoid the attack of drugs. This kind of also contradicts his statement that "CIK cells have a mechanism for recognizing tumors". I haven't searched for this story this year, so I can be patient and look again if you need help.
6. Is there a way to test the effect of the treatment and how much the number of cancer cells in the body has been reduced? I am not sure about this, the hospital told me you can go to take a picture in January after treatment to check if the lump is smaller, because at that time my mom's armpit lump was not big, plus she went back to her hometown after the treatment, I didn't go to check. But my mom said she didn't feel it. My mom was post breast cancer surgery and had lymph node lumps in her armpits. And there are people in our neighboring village who have been treated and died within a few months. And the hospital guarantees to extend life by 1-2 years or even longer.
What is autologous cellular immunotherapy
Autologous cellular immunotherapy is also known as cellular therapy in bioimmunotherapy, which mainly consists of three types of immune cell therapies - DC cellular therapy, CIK cellular therapy, and DCCIK cellular therapy. The specific method is: through the extraction of immature immune cells in the patient's body (blood collection), in the laboratory for the activation of the culture so that it has the ability to efficiently identify and kill liver disease cells, and then back to the patient's body. Patients only need to cooperate to do blood collection and back transfusion of blood two steps, without hospitalization.
Therapy advantages highlighted in: through the collection of human body autoimmune cells, through the in vitro culture to make the number of thousands of times more, and then make the immune cells targeted killing function enhancement, and then transfused back to the body in order to kill the blood and tissues in the pathogens, cancer cells, mutant cells, to break the body's immune tolerance, activate and enhance the body's immune system, with the treatment and prevention of dual efficacy.
Harbin Infectious Diseases Hospital Liver Disease Cell Therapy Center follows the pace of the times, and has established remote consultation and scientific research collaboration with a number of authoritative medical institutions at home and abroad, and has formed the three major projects of "Hepatitis B autoimmunotherapy, cirrhosis SCT cell transplantation, liver cancer multi-cellular biotherapy" as the core of its characteristic technology, which is in line with the international standards and leading the way. The specialty technology is in line with the international standard and leading the domestic market.
Autoimmune therapy is an emerging mode of liver disease treatment for hepatitis B, hepatitis C, cirrhosis and liver cancer with remarkable curative effect. It is a new treatment method of autoimmune anti-hepatitis virus, which fights against hepatitis virus by utilizing a variety of cells, using the principle of applying biotechnology to the immune cells collected from the patient's body after in vitro cultivation and expansion and then infused back into the patient's body to treat the virus in the patient's body. The principle of using is: using biotechnology to culture and expand the immune cells collected from the patient's body in vitro and then infuse them back into the patient's body to carry out precise, targeted and active attacks on the viral cells in the patient's body, destroying the micro-environment in which the virus survives, so as to completely eliminate the virus.
DC-CIK cell therapy is an immune cell therapy technology that jointly applies DC and CIK cells for the treatment of hepatitis B. The two cells are cultured separately, and then co-infused in a reasonable way. The cultured mature DC is presented to CD8+ T cells and CD4+ T cells through the rich antigenic peptide-MHC class I molecular complexes and antigenic peptide-MHC class II molecular complexes on the surface of the membrane, and directly stimulates the T cells and CD4+ T cells of the body. CIK cells kill hepatitis B virus-infected hepatocytes by exerting their own cytotoxicity and secreting cytokines. The combined use of the two can ensure a highly effective anti-hepatitis B virus treatment effect.
The study found that the number of DCs in patients with hepatitis B is significantly lower than that of healthy patients, and their morphological development is also immature, and their expression of the co-stimulatory molecules CD80 and CD86 is also significantly reduced, which indicates that the DCs of patients with hepatitis B have abnormalities and defects not only in their number, but also in the function of antigen presentation, which is one of the important reasons leading to the infection of HBV. Therefore, if we can increase the number and/or improve the function of DC in patients when treating HBV infection, it will help to eliminate HBV.